Detalles de la búsqueda
1.
Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.
Lancet;
400(10366): 1858-1868, 2022 11 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36368336
2.
Children living with HIV in Europe: do migrants have worse treatment outcomes?
HIV Med;
23(2): 186-196, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34596323
3.
Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa.
J Antimicrob Chemother;
72(5): 1450-1455, 2017 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28160504
4.
The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data.
BMC Infect Dis;
17(1): 160, 2017 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28222702
5.
High rate of HIV resuppression after viral failure on first-line antiretroviral therapy in the absence of switch to second-line therapy.
Clin Infect Dis;
58(7): 1023-6, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24352348
6.
T-wave morphology abnormalities in the STREAM stage 1 trial.
Expert Opin Drug Saf;
23(4): 469-476, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38462751
7.
Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial.
JAMA;
308(4): 353-61, 2012 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-22820788
8.
Keeping up with the guidelines: design changes to the STREAM stage 2 randomised controlled non-inferiority trial for rifampicin-resistant tuberculosis.
Trials;
23(1): 474, 2022 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35672833
9.
Impact of the N348I mutation in HIV-1 reverse transcriptase on nonnucleoside reverse transcriptase inhibitor resistance in non-subtype B HIV-1.
Antimicrob Agents Chemother;
55(4): 1806-9, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21282419
10.
Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir.
J Infect Dis;
201(1): 106-13, 2010 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19938977
11.
A virological benefit from an induction/maintenance strategy: the Forte trial.
Antivir Ther;
12(1): 47-54, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17503747
12.
Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa.
AIDS Res Hum Retroviruses;
31(10): 1032-7, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26258548
13.
Prevalence, incidence, and associated risk factors of tuberculosis in children with HIV living in the UK and Ireland (CHIPS): a cohort study.
Lancet HIV;
2(12): e530-9, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26614967
14.
Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial.
Pediatr Infect Dis J;
22(1): 56-62, 2003 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-12544410
15.
High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial.
PLoS One;
9(3): e90772, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24625508
16.
A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria.
PLoS One;
8(2): e57580, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23437399
17.
Evolution of drug resistance during 48 weeks of zidovudine/lamivudine/tenofovir in the absence of real-time viral load monitoring.
J Acquir Immune Defic Syndr;
55(2): 277-83, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20686411
18.
Lack of minority K65R-resistant viral populations detected after repeated treatment interruptions of tenofovir/zidovudine and lamivudine in a resource-limited setting.
J Acquir Immune Defic Syndr;
54(2): 215-6, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20505473
19.
Interval-censored survival time data: confidence intervals for the non-parametric survivor function.
Stat Med;
23(7): 1131-45, 2004 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15057882
Resultados
1 -
19
de 19
1
Próxima >
>>